These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 24824549

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The conservative view: is it necessary to implant a stent into the dopamine transporter?
    Schmid D, Koenig X, Bulusu S, Schicker K, Freissmuth M, Sitte HH, Sandtner W.
    Br J Pharmacol; 2015 Oct; 172(19):4775-8. PubMed ID: 24824446
    [Abstract] [Full Text] [Related]

  • 3. A quantitative model of amphetamine action on the 5-HT transporter.
    Sandtner W, Schmid D, Schicker K, Gerstbrein K, Koenig X, Mayer FP, Boehm S, Freissmuth M, Sitte HH.
    Br J Pharmacol; 2014 Feb; 171(4):1007-18. PubMed ID: 24251585
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.
    Schuldiner S, Steiner-Mordoch S, Yelin R, Wall SC, Rudnick G.
    Mol Pharmacol; 1993 Dec; 44(6):1227-31. PubMed ID: 7903417
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
    Gobbi M, Moia M, Pirona L, Ceglia I, Reyes-Parada M, Scorza C, Mennini T.
    J Neurochem; 2002 Sep; 82(6):1435-43. PubMed ID: 12354291
    [Abstract] [Full Text] [Related]

  • 10. Acceleration of serotonin transporter transport-associated current by 3,4-methylenedioxymethamphetamine (MDMA) under acidic conditions.
    Yamauchi Y, Izumi T, Unemura K, Uenishi Y, Nakagawa T, Kaneko S.
    Neurosci Lett; 2007 Nov 27; 428(2-3):72-6. PubMed ID: 17949903
    [Abstract] [Full Text] [Related]

  • 11. Rat brain serotonin neurones that express neuronal nitric oxide synthase have increased sensitivity to the substituted amphetamine serotonin toxins 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.
    De Silva DJ, French SJ, Cheung NY, Swinson AK, Bendotti C, Rattray M.
    Neuroscience; 2005 Nov 27; 134(4):1363-75. PubMed ID: 16054768
    [Abstract] [Full Text] [Related]

  • 12. Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake.
    Saldaña SN, Barker EL.
    Neurosci Lett; 2004 Jan 16; 354(3):209-12. PubMed ID: 14700733
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of neuronal nitric oxide synthase suppresses the maintenance but not the induction of psychomotor sensitization to MDMA ('Ecstasy') and p-chloroamphetamine in mice.
    Anderson KL, Itzhak Y.
    Nitric Oxide; 2003 Aug 16; 9(1):24-32. PubMed ID: 14559429
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M.
    Am J Psychiatry; 2004 Jul 16; 161(7):1181-9. PubMed ID: 15229049
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.